|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM273707019 |
| 003 |
DE-627 |
| 005 |
20250221230243.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2017 xx |||||o 00| ||jpn c |
| 024 |
7 |
|
|a 10.14989/ActaUrolJap_63_6_239
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n0912.xml
|
| 035 |
|
|
|a (DE-627)NLM273707019
|
| 035 |
|
|
|a (NLM)28694417
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Akahane, Mizuho
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A Case Report
|b Metastatic Carcinoma of the Collecting Ducts of Bellini in a Hemodialysis Patient Treated with Temsirolimus
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 30.10.2017
|
| 500 |
|
|
|a Date Revised 23.10.2018
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Carcinoma of the collecting ductsof Bellini isa rare histological subtype of renal cell carcinoma and mostly has unfavorable prognosis. Radical nephrectomy is generally chosen for the 1st line treatment but therapeutic approaches for the metastasis/recurrence have not been established. We report a case of carcinoma of collecting ducts of Bellini in a patient receiving hemodialysis treated with temsirolimus. A 62- year-old man receiving hemodialysis was admitted to our hospital with drug-resistant anemia and high-grade cyclic fever. Computed tomography revealed the right renal tumor and multiple metastatic lung tumors. Open radical nephrectomy wasperformed. Pathological findingswere compatible with carcinoma of the collecting ducts of Bellini. He was given weekly temsirolimus treatment. The disease progressed modestly but kept the stable disease (SD) status for six months. He died of the cancer 11 months after the initial diagnosis
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
| 650 |
|
7 |
|a temsirolimus
|2 NLM
|
| 650 |
|
7 |
|a 624KN6GM2T
|2 NLM
|
| 650 |
|
7 |
|a Sirolimus
|2 NLM
|
| 650 |
|
7 |
|a W36ZG6FT64
|2 NLM
|
| 700 |
1 |
|
|a Nakashima, Masakazu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sakamoto, Hiromasa
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aoyama, Teruyoshi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kawai, Jun
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 63(2017), 6 vom: 10. Juni, Seite 239-243
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:63
|g year:2017
|g number:6
|g day:10
|g month:06
|g pages:239-243
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.14989/ActaUrolJap_63_6_239
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 63
|j 2017
|e 6
|b 10
|c 06
|h 239-243
|